The company reported H1 FY18 results which were in line with our estimates. Recently, the company upgraded its revenue guidance, resulting in a significant jump in the stock price (up 16% in two trading sessions), post which the higher leverage level and significant integration risk wiped out most of these gains. The company successfully raised €550m at 1.38% (vs the average cost of debt of c.3.5%, which should fall further in the near future). We have tweaked our estimates slightly. No
22 Aug 2018
Eurofins - H1 FY18 in line with expectations
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Eurofins - H1 FY18 in line with expectations
Eurofins Scientific SE (ESF:WBO) | 0 0 1.6% | Mkt Cap: 8,723m
- Published:
22 Aug 2018 -
Author:
Ankush Kathuria -
Pages:
3
The company reported H1 FY18 results which were in line with our estimates. Recently, the company upgraded its revenue guidance, resulting in a significant jump in the stock price (up 16% in two trading sessions), post which the higher leverage level and significant integration risk wiped out most of these gains. The company successfully raised €550m at 1.38% (vs the average cost of debt of c.3.5%, which should fall further in the near future). We have tweaked our estimates slightly. No